# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000059478-22-000100
Filing Date
2022-03-18
Accepted
2022-03-18 16:16:19
Documents
5

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | llydef14a2022_additionalxm.htm | DEFA14A | 12585
2 |  | lly_noticexpagex1a.jpg | GRAPHIC | 507311
3 |  | lly_noticexpagex2a.jpg | GRAPHIC | 499239
4 |  | lly_noticexpagex3a.jpg | GRAPHIC | 507615
5 |  | lly_noticexpagex4a.jpg | GRAPHIC | 499546
| Complete submission text file | 0000059478-22-000100.txt |  | 2786037

Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filer) CIK: 0000059478 (see all company filings)

EIN.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-06351 | Film No.: 22752743
SIC: 2834 Pharmaceutical Preparations